PMID- 37838157 OWN - NLM STAT- MEDLINE DCOM- 20231225 LR - 20231225 IS - 1538-2990 (Electronic) IS - 0002-9629 (Linking) VI - 367 IP - 1 DP - 2024 Jan TI - The expanding role of HLA gene tests for predicting drug side effects. PG - 14-20 LID - S0002-9629(23)01375-7 [pii] LID - 10.1016/j.amjms.2023.10.004 [doi] AB - Adverse drug reactions can be either dose-dependent (Type A) or idiosyncratic (Type B). Type B adverse drug reactions tend to be extremely rare and difficult to predict. They are usually immune-mediated. Examples include severe skin reactions and drug-induced liver injury. For many commonly prescribed drugs (such as antibiotics), the risk of developing an idiosyncratic adverse drug reaction is influenced by variability in the human leukocyte antigen (HLA) genes. Because these HLA-mediated adverse drug reactions can be lethal, there is growing interest in defining which specific drug-gene relationships might benefit from pre-emptive HLA genotyping and automated clinical decision support. This review summarizes the literature for HLA-mediated adverse reactions linked to common drugs. CI - Copyright (c) 2023 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved. FAU - Petry, Natasha AU - Petry N AD - School of Pharmacy, North Dakota State University, Fargo, ND 58102, USA. FAU - Forest, Kennedy AU - Forest K AD - Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA. FAU - Wilke, Russell A AU - Wilke RA AD - Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA. Electronic address: russell.wilke@usd.edu. LA - eng PT - Journal Article PT - Review DEP - 20231012 PL - United States TA - Am J Med Sci JT - The American journal of the medical sciences JID - 0370506 RN - 0 (HLA Antigens) RN - 0 (Anti-Bacterial Agents) SB - IM MH - Humans MH - HLA Antigens/genetics/pharmacology MH - *Drug-Related Side Effects and Adverse Reactions/diagnosis/genetics MH - *Chemical and Drug Induced Liver Injury/etiology/genetics MH - Skin MH - Anti-Bacterial Agents OTO - NOTNLM OT - Adverse drug reaction OT - Decision support OT - Pharmacogenetics EDAT- 2023/10/15 05:45 MHDA- 2023/12/25 06:41 CRDT- 2023/10/14 19:26 PHST- 2023/08/23 00:00 [received] PHST- 2023/10/09 00:00 [accepted] PHST- 2023/12/25 06:41 [medline] PHST- 2023/10/15 05:45 [pubmed] PHST- 2023/10/14 19:26 [entrez] AID - S0002-9629(23)01375-7 [pii] AID - 10.1016/j.amjms.2023.10.004 [doi] PST - ppublish SO - Am J Med Sci. 2024 Jan;367(1):14-20. doi: 10.1016/j.amjms.2023.10.004. Epub 2023 Oct 12.